Method for establishing platform for analyzing and predicting cognitive impairment of diabetes based on metabonomics data
A technology of cognitive dysfunction and metabolomics data, applied in the field of analysis and prediction platform establishment, to achieve the effect of reducing morbidity and avoiding deterioration
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0030] Follow the steps below:
[0031] a. Take three groups of frozen plasma samples, which are healthy people in group A; patients with diabetes but not in group B
[0032] Suffering from cognitive dysfunction; group C diabetic patients but suffering from cognitive dysfunction; each group took 24 samples, and the three groups of plasma samples were thawed at room temperature for 15 minutes and vortexed for 5 seconds; 100μl of each sample was added to 300μl HPLC grade methanol, vortex and shake for 30s, and stand for 20min at 4°C; perform refrigerated centrifugation on all samples, 12000rpm, 4°C, 15min, and take the supernatant of each sample;
[0033] b. Pass the supernatant of each sample into LC / MS for separation;
[0034] The LC / MS instrument analysis platform is Agilent, 1290 Infinity LC, 6530 UHD and Accurate-Mass Q-TOF / MS.
[0035] Chromatographic conditions: The separation chromatographic column is a C18 chromatographic column (Agilent, 100 mm×2.1 mm, 1.8μm), and the separat...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com